Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehisa Kitano

Showing results (21-30 of 150) with videos related to

Pageof 15
Sort By:
Cancer Science|April 12, 2020
CD20<sup>+</sup> tumor-infiltrating immune cells and CD204<sup>+</sup> M2 macrophages are associated with prognosis in thymic carcinomaJun Sato, Shigehisa Kitano, Noriko Motoi, et al.
International Journal of Clinical Oncology|March 16, 2017
Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in JapanAkihiko Shimomura, Shunsuke Kondo, Noriko Kobayashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 1, 2024
Loss of phosphatase and tensin homolog expression castration-sensitive prostate cancer predicts outcomes in men after prostatectomyYoshinori Yanai, Shuji Mikami, Yota Yasumizu, et al.
Scientific Reports|January 28, 2016
A novel method for evaluating antibody-dependent cell-mediated cytotoxicity by flowcytometry using cryopreserved human peripheral blood mononuclear cellsMakiko Yamashita, Shigehisa Kitano, Hiroaki Aikawa, et al.
Human Pathology|November 11, 2017
Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinomaFumie Igari, Eiichi Sato, Yoshiya Horimoto, et al.
Cancer Science|January 23, 2024
Interleukin-4 induced 1-mediated resistance to an immune checkpoint inhibitor through suppression of CD8<sup>+</sup> T cell infiltration in melanomaShiho Hirose, Tetsuo Mashima, Xunmei Yuan, et al.
The Journal of Dermatology|April 5, 2019
Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumabYusuke Muto, Shigehisa Kitano, Arata Tsutsumida, et al.
Immunotherapy|October 3, 2015
Tremelimumab-associated tumor regression following after initial progression: two case reportsAkihiko Shimomura, Yutaka Fujiwara, Shunsuke Kondo, et al.
Biochemistry and Biophysics Reports|September 29, 2017
Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine modelNorihiro Fujinami, Toshiaki Yoshikawa, Yu Sawada, et al.
Lung Cancer (Amsterdam, Netherlands)|May 26, 2020
Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinomaNobumasa Tamura, Yutaka Fujiwara, Taiki Hashimoto, et al.
Pageof 15

Showing results (21-30 of 150) with videos related to

Sort By:
Pageof 15
Cancer Science|April 12, 2020
CD20<sup>+</sup> tumor-infiltrating immune cells and CD204<sup>+</sup> M2 macrophages are associated with prognosis in thymic carcinomaJun Sato, Shigehisa Kitano, Noriko Motoi, et al.
International Journal of Clinical Oncology|March 16, 2017
Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in JapanAkihiko Shimomura, Shunsuke Kondo, Noriko Kobayashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 1, 2024
Loss of phosphatase and tensin homolog expression castration-sensitive prostate cancer predicts outcomes in men after prostatectomyYoshinori Yanai, Shuji Mikami, Yota Yasumizu, et al.
Scientific Reports|January 28, 2016
A novel method for evaluating antibody-dependent cell-mediated cytotoxicity by flowcytometry using cryopreserved human peripheral blood mononuclear cellsMakiko Yamashita, Shigehisa Kitano, Hiroaki Aikawa, et al.
Human Pathology|November 11, 2017
Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinomaFumie Igari, Eiichi Sato, Yoshiya Horimoto, et al.
Cancer Science|January 23, 2024
Interleukin-4 induced 1-mediated resistance to an immune checkpoint inhibitor through suppression of CD8<sup>+</sup> T cell infiltration in melanomaShiho Hirose, Tetsuo Mashima, Xunmei Yuan, et al.
The Journal of Dermatology|April 5, 2019
Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumabYusuke Muto, Shigehisa Kitano, Arata Tsutsumida, et al.
Immunotherapy|October 3, 2015
Tremelimumab-associated tumor regression following after initial progression: two case reportsAkihiko Shimomura, Yutaka Fujiwara, Shunsuke Kondo, et al.
Biochemistry and Biophysics Reports|September 29, 2017
Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine modelNorihiro Fujinami, Toshiaki Yoshikawa, Yu Sawada, et al.
Lung Cancer (Amsterdam, Netherlands)|May 26, 2020
Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinomaNobumasa Tamura, Yutaka Fujiwara, Taiki Hashimoto, et al.
Pageof 15